Why EMPA-REG Results Make This a “Very Exciting Time” in Diabetes Care

Описание к видео Why EMPA-REG Results Make This a “Very Exciting Time” in Diabetes Care

Dennis P. Scanlon, PhD; Zachary T. Bloomgarden, MD, MACE; Robert Gabbay, MD, PhD, FACP; Michael Gardner, MD; and John A. Johnson, MD, MBA; discuss the results of recent clinical trials that evaluated cardiovascular outcomes associated with various diabetes treatments when used as add-on therapy.

Комментарии

Информация по комментариям в разработке